← Back to headlines
Novo Nordisk Drug Shows Significant Weight and Blood Sugar Reduction in China Trials
A new drug from Novo Nordisk has demonstrated greater weight loss and lower blood sugar levels compared to placebo and semaglutide in phase 2 trials conducted in China.
Sources
Showing 0 of 3 sources
No articles available in your preferred languages.
3 articles available in other languages below.
dr-dkDanish1h ago
Nyt Novo-middel viser fald i vægt og blodsukker i fase 2-studie i Kina
Read full article →politikenDanish1h ago
Nyt Novo-middel viser reduktion i vægt og blodsukker i Kina
Nyt lægemiddel fra Novo Nordisk viser større vægttab og lavere blodsukkerniveau end ved placebo og semaglutid.
Read full article →berlingskeDanish1h ago
Nyt Novo-middel viser reduktion i vægt og blodsukker i Kina
Nyt lægemiddel fra Novo Nordisk viser større vægttab og lavere blodsukkerniveau end ved placebo og semaglutid.
Read full article →Coverage Timeline
First report: berlingske · 25 Mar, 06:45|Full coverage: 3 · 51m|Window: 51m
Left-leaningCenterRight-leaning
Related Stories
Jeepney Drivers in Iligan City Stage Three-Day Transport Strike Over Fuel Costs
just now
Philippine President Marcos Jr. Signs Fuel Excise Tax Suspension Bill Amid Energy Emergency
just now
PNP logs 415 gas station closures amid oil supply crisis
just now
Lawyers Urge Supreme Court Action on Naia Fee Hikes Petition
just now